Arjomand
VP
Pharma & Healthcare
genea
Australia
Biography
Dr Arjomand has 13 years of pharmaceutical and biotechnology experience and co-authored 8 scientific publications. He joined Genea Biocells in 2013 and established a pipeline of leads for contract research services and successfully set up multiple strategic partnerships to facilitate Genea Biocells’ long term goals. Previously, Dr Arjomand was the Director of Basic Research at High Q Foundation/CHDI Management (USA) a not-for-profit foundation dedicated to Huntington’s disease (HD) therapeutics. He designed and managed a complex portfolio comprising of academic, clinical and industry driven projects in support of Foundation drug discovery efforts.
Research Interest
Pharma & Healthcare
